These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7951676)

  • 21. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
    Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.
    Pollanen MS; Bergeron C; Weyer L
    Acta Neuropathol; 1994; 88(1):1-6. PubMed ID: 7524261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lewy body dementia--clinical, pathological and neurochemical interconnections.
    Perry R; McKeith I; Perry E
    J Neural Transm Suppl; 1997; 51():95-109. PubMed ID: 9470131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
    Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
    J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    Siedlak SL; Jiang Y; Huntley ML; Wang L; Gao J; Xie F; Liu J; Su B; Perry G; Wang X
    J Alzheimers Dis; 2017; 58(4):1027-1033. PubMed ID: 28527219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.
    Goedert M; Spillantini MG; Cairns NJ; Crowther RA
    Neuron; 1992 Jan; 8(1):159-68. PubMed ID: 1530909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
    Smith TW; Lippa CF
    J Neuropathol Exp Neurol; 1995 May; 54(3):297-303. PubMed ID: 7745428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
    Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
    Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.
    Benjamin R; Leake A; Ince PG; Perry RH; McKeith IG; Edwardson JA; Morris CM
    Neurodegeneration; 1995 Dec; 4(4):443-8. PubMed ID: 8846238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
    Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
    Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.